Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reflect.com

This article was originally published in The Rose Sheet

Executive Summary

Virginia Kent appointed to CEO of the joint venture beauty care Web site from Procter & Gamble and Internet investor firm Institutional Venture Partners. Kent joined reflect.com from Hasbro, where she was president of the U.S. toy sector. P&G Global Beauty Care and North America President Allen Lafley served as interim CEO since the companies announced the site in September (1"The Rose Sheet" Sept. 20, p. 5). The San Francisco-based customized site is set to launch in March (2"The Rose Sheet" Nov. 22, p. 7)

You may also be interested in...



Reflect.com Web Site Adjusts To User's Personality; March Launch Set

Procter & Gamble's reflect.com e-commerce site is designed to "adjust to each woman's personality," according to reflect.com Interim CEO Denis Beausejour.

P&G Start-Up Reflect.com To Offer 50,000 Customized Beauty Products

Proctor & Gamble is launching a new stand-alone, interactive Web site called reflect.com during the preholiday season with personalized beauty products for Internet savvy women, the cosmetics and consumer products marketer announced Sept. 13.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel